By Josh White
Date: Wednesday 12 Feb 2025
(Sharecast News) - Oxford BioDynamics announced on Wednesday that it has signed a distribution agreement with Regina Maria, Romania's largest private healthcare provider, to offer its EpiSwitch PSE and CiRT blood tests to physicians and patients across the country.
By Josh White
Date: Wednesday 05 Feb 2025
(Sharecast News) - Oxford BioDynamics announced the publication of a multi-institutional clinical study on Wednesday, confirming the accuracy of its EpiSwitch Colorectal No-Stool Test (NST) in detecting colorectal cancer and precancerous polyps using a blood sample.
By Josh White
Date: Friday 17 Jan 2025
(Sharecast News) - Oxford BioDynamics, a precision clinical diagnostics company leveraging its 'EpiSwitch 3D' genomics platform, announced the successful completion of its fundraising initiative on Friday.
Currency | UK Pounds |
Share Price | 0.48p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 9.31p |
52 Week Low | 0.45p |
Volume | 3,860,472 |
Shares Issued | 1,957.58m |
Market Cap | £9.30m |
Value | ![]() |
---|
Price Trend | ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
13:03 | 54,347 @ 0.46p |
12:28 | 32,000 @ 0.49p |
12:19 | 6,333 @ 0.45p |
11:38 | 500,000 @ 0.45p |
10:38 | 2,000,000 @ 0.46p |
You are here: research